Sowell Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,520
Closed -$26K 3040
2021
Q1
$26K Buy
4,520
+1,635
+57% +$11K ﹤0.01% 1947
2020
Q4
$14K Sell
2,885
-665
-19% -$3.36K ﹤0.01% 1897
2020
Q3
$21K Sell
3,550
-360
-9% -$2.15K ﹤0.01% 1552
2020
Q2
$26K Buy
3,910
+700
+22% +$5.3K ﹤0.01% 1384
2020
Q1
$20K Hold
3,210
﹤0.01% 1405
2019
Q4
$33K Buy
3,210
+2,545
+383% +$18.5K ﹤0.01% 1291
2019
Q3
$3K Buy
+665
New +$5.38K ﹤0.01% 2005

Other funds holding CLVS

Sowell Financial Services's CLVS Position: Q2 2021 in Review

Sowell Financial Services sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 4,520 shares — an estimated $26K sold.

Sowell Financial Services first reported a position in CLVS in Q3 2019 and held it in 7 quarters. The position peaked at $33K in Q4 2019. 161 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Sowell Financial Services reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 4,520 Clovis Oncology, Inc. shares in Q2 2021, an estimated $26K.
  • Sowell Financial Services first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Clovis Oncology, Inc. position peaked at $33K in Q4 2019.
  • 161 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.